Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
191.4 USD | -0.52% | +8.03% | -11.78% |
Jun. 06 | Transcript : Insulet Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:00 AM | |
May. 30 | Redburn Atlantic Initiates Insulet With Buy Rating, $235 Price Target | MT |
Evolution of the average Target Price on Insulet Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Insulet Corporation
Redburn Atlantic | |
Raymond James | |
Wolfe Research | |
Canaccord Genuity | |
Jefferies & Co. | |
Stifel Nicolaus | |
Barclays | |
UBS | |
Baird | |
Morgan Stanley | |
BofA Securities | |
Citigroup | |
Piper Sandler | |
BTIG | |
Baptista Research | |
JPMorgan Chase | |
SVB Leerink | |
Oppenheimer | |
Berenberg Bank | |
Cowen |
EPS Revisions
- Stock Market
- Equities
- PODD Stock
- Consensus Insulet Corporation